A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer

Abstract Background Everolimus is a mechanistic-target-of-rapamycin (mTOR) inhibitor bearing a potent antitumor effect against hormone receptor-positive breast cancer. Here, we report the case of a patient with recurrent breast cancer who developed osteomyelitis during the treatment with everolimus...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaori Abe, Masafumi Shimoda, Tetsuhiro Yoshinami, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Naofumi Kagara, Yasuto Naoi, Kenzo Shimazu
Format: Article
Language:English
Published: Japan Surgical Society 2022-01-01
Series:Surgical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s40792-022-01376-y
Tags: Add Tag
No Tags, Be the first to tag this record!